Axa’s Procter & Gamble PG Stock Holding History

Axa’s Portfolio PG Stock Details PG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,643,986	Closed	-$262M	–	782
2025 Q2	$262M	Buy	1,643,986 +162,870	+11%	+$26.6M	0.75%	21
2025 Q1	$252M	Buy	1,481,116 +98,133	+7%	+$16.4M	0.83%	17
2024 Q4	$232M	Sell	1,382,983 -83,554	-6%	-$14.2M	0.7%	21
2024 Q3	$254M	Buy	1,466,537 +47,102	+3%	+$8M	0.75%	22
2024 Q2	$234M	Sell	1,419,435 -28,110	-2%	-$4.6M	0.7%	24
2024 Q1	$235M	Buy	1,447,545 +151,349	+12%	+$23.7M	0.7%	24
2023 Q4	$190M	Sell	1,296,196 -12,599	-1%	-$1.87M	0.61%	28
2023 Q3	$191M	Buy	1,308,795 +250,835	+24%	+$38.3M	0.67%	24
2023 Q2	$161M	Sell	1,057,960 -312,578	-23%	-$47.1M	0.53%	34
2023 Q1	$204M	Buy	1,370,538 +85,691	+7%	+$12.2M	0.7%	22
2022 Q4	$195M	Buy	1,284,847 +222,325	+21%	+$31.2M	0.7%	18
2022 Q3	$134M	Buy	1,062,522 +165,788	+18%	+$23.6M	0.53%	31
2022 Q2	$129M	Sell	896,734 -47,955	-5%	-$7.21M	0.48%	42
2022 Q1	$144M	Sell	944,689 -48,382	-5%	-$7.57M	0.41%	45
2021 Q4	$162M	Sell	993,071 -29,743	-3%	-$4.42M	0.42%	46
2021 Q3	$143M	Sell	1,022,814 -9,687	-0.9%	-$1.37M	0.4%	52
2021 Q2	$139M	Sell	1,032,501 -40,967	-4%	-$5.54M	0.39%	51
2021 Q1	$145M	Buy	1,073,468 +24,368	+2%	+$3.18M	0.44%	42
2020 Q4	$146M	Buy	1,049,100 +33,557	+3%	+$4.69M	0.46%	39
2020 Q3	$141M	Sell	1,015,543 -66,200	-6%	-$8.79M	0.51%	34
2020 Q2	$129M	Sell	1,081,743 -161,152	-13%	-$18.8M	0.51%	35
2020 Q1	$137M	Buy	1,242,895 +224,049	+22%	+$26.9M	0.68%	25
2019 Q4	$127M	Sell	1,018,846 -15,581	-2%	-$1.91M	0.52%	32
2019 Q3	$129M	Sell	1,034,427 -124,638	-11%	-$14.7M	0.51%	31
2019 Q2	$127M	Buy	1,159,065 +12,918	+1%	+$1.38M	0.5%	33
2019 Q1	$119M	Sell	1,146,147 -4,497	-0.4%	-$438K	0.47%	37
2018 Q4	$106M	Sell	1,150,644 -55,180	-5%	-$4.93M	0.46%	40
2018 Q3	$100M	Buy	1,205,824 +243,803	+25%	+$19.9M	0.37%	65
2018 Q2	$75.1M	Buy	962,021 +19,921	+2%	+$1.5M	0.29%	92
2018 Q1	$74.7M	Sell	942,100 -126,776	-12%	-$10.6M	0.3%	90
2017 Q4	$98.2M	Buy	1,068,876 +1	+0%	+$90	0.39%	57
2017 Q3	$97.2M	Sell	1,068,875 -30,498	-3%	-$2.78M	0.42%	49
2017 Q2	$95.8M	Sell	1,099,373 -45,593	-4%	-$4.02M	0.44%	46
2017 Q1	$103M	Sell	1,144,966 -205,462	-15%	-$18.2M	0.46%	46
2016 Q4	$114M	Sell	1,350,428 -269,716	-17%	-$23M	0.53%	34
2016 Q3	$145M	Sell	1,620,144 -51,735	-3%	-$4.49M	0.64%	25
2016 Q2	$142M	Buy	1,671,879 +6,214	+0.4%	+$510K	0.63%	27
2016 Q1	$137M	Buy	1,665,665 +55,121	+3%	+$4.44M	0.62%	33
2015 Q4	$128M	Sell	1,610,544 -170,254	-10%	-$13M	0.56%	38
2015 Q3	$128M	Buy	1,780,798 +83,463	+5%	+$6.26M	0.53%	38
2015 Q2	$133M	Buy	1,697,335 +250,241	+17%	+$20.1M	0.53%	36
2015 Q1	$119M	Sell	1,447,094 -81,421	-5%	-$7M	0.49%	41
2014 Q4	$139M	Sell	1,528,515 -6,530	-0.4%	-$575K	0.56%	41
2014 Q3	$129M	Buy	1,535,045 +1,372	+0.1%	+$112K	0.55%	39
2014 Q2	$121M	Buy	1,533,673 +92,280	+6%	+$7.44M	0.5%	44
2014 Q1	$116M	Sell	1,441,393 -53,171	-4%	-$4.19M	0.51%	41
2013 Q4	$122M	Sell	1,494,564 -91,490	-6%	-$7.45M	0.54%	34
2013 Q3	$120M	Sell	1,586,054 -84,025	-5%	-$6.69M	0.59%	32
2013 Q2	$129M	Buy	+1,670,079	New	+$131M	0.68%	28

Other funds holding PG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Axa's PG Position: Q3 2025 in Review

Axa sold out of Procter & Gamble (PG) in Q3 2025, closing a stake of 1,643,986 shares — an estimated $262M sold.

Axa first reported a position in PG in Q2 2013 and held it in 49 quarters. The position peaked at $262M in Q2 2025. 3,892 funds tracked by Wall St. Rank hold PG as of Q3 2025.

Axa reported no remaining Procter & Gamble position as of Q3 2025 after selling out during the quarter.
Axa sold 1,643,986 Procter & Gamble shares in Q3 2025, an estimated $262M.
Axa first reported a position in Procter & Gamble in Q2 2013 and held it in 49 quarters.
Axa's Procter & Gamble position peaked at $262M in Q2 2025.
3,892 funds tracked by Wall St. Rank held Procter & Gamble as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.